Infectious disease. Research (genomics) is crucial to attacking malaria.
Solving the enormous problem of malaria worldwide will require a balance between investments in research and control. In this point-counterpoint, two scientists describe the rationales for these very different strategies. Steve Hoffman believes that genomics research is the best investment in the future if we have the vision of malaria eradication. Chris Curtis presents an opposing viewpoint, that low-tech control approaches are the practical ones under current conditions.
Hoffman
S L
SL
Naval Medical Research Center, Silver Spring, MD 20910-7500, USA. hoffmans@nmrc.navy.mil
D000818:Animals; D000852:Anopheles / Q000235:genetics*; D000962:Antimalarials / Q000494:pharmacology / Q000627:therapeutic use; D017344:Genes, Insect; D017125:Genes, Protozoan; D015894:Genome, Human; D023281:Genomics; D006801:Humans; D007303:Insect Vectors / Q000235:genetics; D008288:Malaria / Q000453:epidemiology / Q000469:parasitology / Q000517:prevention & control* / Q000635:transmission; D017780:Malaria Vaccines; D016778:Malaria, Falciparum / Q000453:epidemiology / Q000469:parasitology / Q000517:prevention & control / Q000635:transmission; D010961:Plasmodium / Q000187:drug effects / Q000235:genetics*; D010963:Plasmodium falciparum / Q000187:drug effects / Q000235:genetics; D012106:Research
D000962:Antimalarials; D017780:Malaria Vaccines